| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |